Skip to content

Comparison of Gastric Volume Changes After Ventilation With Endotracheal Tube, First-Generation Supraglottic Airway, and Second-Generation Supraglottic Airway in Pediatric Patients

Comparison of Gastric Volume Changes Via Ultrasound After Ventilation With Endotracheal Tube, First-Generation Supraglottic Airway, and Second-Generation Supraglottic Airway in Pediatric Patients: A Prospective Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07555080
Enrollment
250
Registered
2026-04-28
Start date
2026-06-15
Completion date
2026-09-01
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Complications, Gastric Insufflation, Gastric Ultrasonography, Gastric Volume, Supraglottic Airways, Supraglottic Airway Use in Children

Keywords

gastric ultrasonography, airway management

Brief summary

This study aims to compare the gastric volumes of pediatric patients undergoing positive-pressure ventilation with different airway management techniques. Gastric ultrasound is a non-invasive bedside tool with high sensitivity and specificity for determining the nature and amount of gastric content. In pediatric cases, maintaining a gastric volume below 1.25 mL/kg is associated with a lower risk of perioperative aspiration. Although supraglottic airway devices (SADs) are commonly used as alternatives to endotracheal tubes, concerns regarding the potential for gastric insufflation and subsequent aspiration persist. Second-generation SADs were specifically designed with gastric drainage channels to mitigate the risk of regurgitation compared to first-generation devices. The primary objective of this study is to determine whether there is a difference in gastric volumes, as measured by ultrasound, among three groups of pediatric patients: those managed with endotracheal tubes, first-generation SADs, and second-generation SADs. By comparing these measurements post-ventilation, the investigators aim to evaluate the impact of the airway device choice on gastric volume under clinical conditions.

Detailed description

All participants will receive a standard preoperative intravenous (IV) dose of 0.1 mg/kg midazolam in the preparation room. Upon arrival at the operating room, routine monitoring will be established for all patients, including electrocardiography (ECG), non-invasive blood pressure (NIBP), and peripheral oxygen saturation (SpO2). Before the induction of anesthesia (T0), the gastric antral area will be evaluated using ultrasound in the right lateral decubitus (RLD) position. A high-frequency linear probe will be placed sagittally in the epigastric region to visualize the stomach antrum, located posterior to the left lobe of the liver and anterior to the abdominal aorta. The largest and smallest diameters (d1 and d2) of the elliptical antrum will be measured. The Antral Cross-Sectional Area (ACSA) will be calculated using the formula: ACSA = d1\*d2\*pi/4. Gastric volume will then be derived using the validated pediatric formula: \[0.035\*ACSA (mm2) + 0.127\*age (months) - 7.8\] / body weight (kg). Standard general anesthesia induction will be performed using sevoflurane and oxygen inhalation, 1 mcg/kg IV fentanyl, and 0.5 mg/kg IV rocuronium. Following induction, patients will be managed with either endotracheal intubation or a supraglottic airway device (SAD). The choice of airway management will follow routine clinical practice. SAD size and cuff inflation volume will adhere to the manufacturer's recommendations. Any volume leakage during ventilation will be recorded as a percentage. Anesthesia maintenance will be provided with 1 MAC sevoflurane in an oxygen/air mixture. The gastric antral area will be re-evaluated via ultrasound in the RLD position at two additional time points: T1: Immediately after the airway device is secured and ventilation is established, before the start of surgery. T2: At the end of the surgical procedure, before the patient emerges from anesthesia. All relevant clinical data will be recorded in the patient follow-up form, including age, gender, height, weight, duration of surgery, vital signs, type of airway device used, perioperative airway pressures, and any observed complications. Following the final measurement, patients will be emerged from anesthesia and transferred to the postoperative recovery room according to standard protocols.

Interventions

None listed

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* 1-10 years of age * Adherence to standard preoperative fasting guidelines * Elective surgeries * ASA I-III status * Surgery time 30 min to 2 hours

Exclusion criteria

* Gastrointestinal tract surgeries * Laparoscopic surgeries * Emergency procedures * Full stomach patients * Lack of parental/guardian consent

Design outcomes

Primary

MeasureTime frameDescription
Comparison of gastric volume changes smong study groupsup to 2 hoursThe primary outcome is to compare the change in gastric volume calculated via ultrasound at T0 (before induction), T1 (after the airway secured), and T2 (end of the operation) among the three groups (Endotracheal tube, first-generation SAD, and second-generation SAD). This will determine whether the choice of airway device leads to a difference in gastric volume during the perioperative period.

Secondary

MeasureTime frameDescription
Correlation between duration of surgery and change in gastric volume30 minutes to 2 hoursTotal duration of the surgical procedure and the change in gastric volume
Antral cross sectional area changesup to 2 hoursMeauserement of antral cross sectional area at T0, T1 and T2 on lateral decubitis position
Air leakegeup to 2 hoursAir leakage percentage with different airway devices
Airway pressuresup to 2 hoursPeak airway pressures during surgery duration
SpO2up to 2 hoursPulse oximeter
Heart rateup to 2 hoursECG monitoring
Mean arteryal pressureup to 2 hoursNon-invasive blood pressure measurement
Airway complicationsup to 3 hoursPerioperative airway complications such as bronchospasm, laryngospasm etc. will be noted

Countries

Turkey (Türkiye)

Contacts

CONTACTMeltem Savran Karadeniz, Professor
mskaradeniz@gmail.com+9005334845563
CONTACTZeynep Sandikci, Resident
zeynepsandikcii@gmail.com+905396076093
PRINCIPAL_INVESTIGATORMeltem Savran Karadeniz

Istanbul University Faculty of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026